Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism GPR75 inhibitors(G protein-coupled receptor 75 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC16H20N4O2 |
InChIKeyGNQGSUOEYQIORN-UHFFFAOYSA-N |
CAS Registry2126874-77-7 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Renal fibrosis | Preclinical | JP | 22 Aug 2023 |